histidine has been researched along with Chronic Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, JS; Beggs, S; Costigan, M; Diatchenko, L; Dorfman, R; Gershon, E; Herbert, TA; John, SL; Jordan, J; Livneh, J; Maixner, W; Mogil, JS; Peltz, G; Ritchie, J; Salter, MW; Seltzer, Z; Slade, GD; Smith, SB; Sorge, RE; Tan, K; Tichauer, D; Trang, T; Vander Meulen, H; Woolf, CJ; Yarkoni-Abitbul, M; Zaykin, DV; Zheng, M | 1 |
1 other study(ies) available for histidine and Chronic Pain
| Article | Year |
|---|---|
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Carbenoxolone; Cells, Cultured; Chronic Pain; Cohort Studies; Connexins; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Linkage; Genome-Wide Association Study; Genotype; Histidine; Humans; Hyperalgesia; Macrophages; Male; Mastectomy; Mice; Mice, Inbred Strains; Mutation; Nerve Tissue Proteins; Osteoarthritis; Pain Measurement; Pain Threshold; Peptides; Polymorphism, Single Nucleotide; Quinolinium Compounds; Receptors, Purinergic P2X7; Retrospective Studies; Species Specificity; Time Factors; Transfection | 2012 |